Insider Transactions in Q4 2022 at Oncocyte Corp (OCX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2022
|
John Peter Gutfreund |
BUY
Open market or private purchase
|
Indirect |
75,000
+50.0%
|
$0
$0.33 P/Share
|
|
Dec 23
2022
|
Andrew Arno Director |
BUY
Open market or private purchase
|
Direct |
250,000
+31.97%
|
$0
$0.35 P/Share
|
|
Dec 22
2022
|
Alfred D Kingsley Director |
BUY
Open market or private purchase
|
Direct |
25,000
+5.39%
|
$0
$0.28 P/Share
|
|
Dec 21
2022
|
Douglas T. Ross Former CSO |
BUY
Grant, award, or other acquisition
|
Direct |
213,797
+47.73%
|
-
|
|
Dec 01
2022
|
Gisela Paulsen Former President and COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
175,000
-32.32%
|
-
|
|
Dec 01
2022
|
Douglas T. Ross Former CSO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
150,000
-88.07%
|
-
|
|
Dec 01
2022
|
Ronald Asbury Andrews Former CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+30.0%
|
-
|